Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Lower Urinary Tract Symptoms|January 12, 2025
Predicting Elevated Postvoid Residual Urine Volume Following OnabotulinumtoxinA Treatment for Overactive Bladder: A Pilot StudyIsrael Franco, Marc Schwartz, Kevin Cline, et al.
Urology|February 8, 2006
Multicenter phase III trial studying trospium chloride in patients with overactive bladderDelbert Rudy, Kevin Cline, Richard Harris, et al.
BJU International|February 14, 2006
Time to onset of improvement in symptoms of overactive bladder using antimuscarinic treatmentDelbert Rudy, Kevin Cline, Richard Harris, et al.
The Journal of Urology|May 6, 2024
Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE TrialDavid Staskin, Janet Owens-Grillo, Elizabeth Thomas, et al.
Urology|September 19, 2024
A Multicenter Prospective Sham-controlled Trial Evaluating a Physiologic Closed-loop Wearable Tibial Neuromodulation System for Overactive BladderColin Goudelocke, Rohit Dhir, Eve Shapiro, et al.
Journal of Minimally Invasive Gynecology|November 18, 2008
Nonsurgical transurethral collagen denaturation for stress urinary incontinence in women: 12-month results from a prospective long-term studyDenise M Elser, Gretchen K Mitchell, John R Miklos, et al.
Advances in Urology|December 23, 2011
Nonsurgical transurethral radiofrequency collagen denaturation: results at three years after treatmentDenise M Elser, Gretchen K Mitchell, John R Miklos, et al.
Neurourology and Urodynamics|October 27, 2010
Nonsurgical transurethral collagen denaturation for stress urinary incontinence in women: 18-month results from a prospective long-term studyDenise M Elser, Gretchen K Mitchell, John R Miklos, et al.
Neurourology and Urodynamics|November 3, 2017
Three-month primary efficacy data for the SUCCESS Trial; a phase III, multi-center, prospective, randomized, controlled study treating female stress urinary incontinence with the vesair intravesical balloonKurt McCammon, Karny Jacoby, Susan Kalota, et al.
Female Pelvic Medicine & Reconstructive Surgery|September 28, 2017
Twelve-Month Efficacy and Safety Data for the "Stress Incontinence Control, Efficacy and Safety Study": A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical BalloonHarvey Winkler, Karny Jacoby, Susan Kalota, et al.
Pageof 2